47 results on '"Dery A"'
Search Results
2. Difference Between Persistent Aneurysm, Regressed Aneurysm, and Coronary Dilation in Kawasaki Disease: An Optical Coherence Tomography Study
3. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
4. Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events
5. Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry
6. Cardiovascular burden and related risk factors among Nunavik (Quebec) Inuit: Insights from baseline findings in the circumpolar Inuit Health in Transition cohort study
7. ANTITHROMBOTIC THERAPIES IN CANADIAN ATRIAL FIBRILLATION PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEASE: INSIGHTS FROM THE CONNECT AF+PCI-I AND -II PROGRAMS
8. USE AND OUTCOME OF DUAL ANTIPLATELET THERAPY FOR ACUTE CORONARY SYNDROME IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT), A MULTICENTRE PROSPECTIVE COHORT STUDY
9. Outpatient percutaneous coronary intervention: Ready for prime time?
10. Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung Institute
11. CONTEMPORARY USE OF ORAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CONNECT AF+PCI STUDY
12. CONTEMPORARY ANTIPLATELET THERAPY IN MODERATE TO HIGH-RISK PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN ACS REFLECTIVE II STUDY
13. DIAGNOSIS AND OUTCOMES OF PATIENTS WITH SUPRAVALVULAR PULMONARY STENOSIS TREATED WITH PERCUTANEOUS BALLOON DILATION
14. DUAL ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROMES: IDENTIFYING FACTORS RESPONSIBLE FOR THE STAGNATION IN THE USE OF NOVEL ANTIPLATELET AGENTS IN A UNIVERSITY TERTIARY CARE CENTER
15. MARITAL STATUS, LIVING ARRANGEMENT, AND OUTCOMES FOLLOWING MYOCARDIAL INFARCTION: OBSERVATIONS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
16. CLOPIDOGREL VERSUS NOVEL P2Y12 INHIBITOR USE IN FIBRINOLYSIS TREATED ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
17. LONG-TERM STATIN USE AND ADHERENCE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUÉBEC REGISTRY
18. ISCHEMIC AND BLEEDING EVENTS IN CANADIAN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WHO REQUIRE ORAL ANTICOAGULATION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
19. SWITCHING AND PREMATURE DISCONTINUATION OF ADP RECEPTOR INHIBITOR THERAPY PRESCRIBED AT HOSPITAL DISCHARGE AMONG MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
20. DURATION OF DUAL ANTIPLATELET THERAPY AND ASSOCIATED OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTION: CONTEMPORARY PRACTICE INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
21. ADP RECEPTOR INHIBITOR USE AND SWITCHING IN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
22. IN-HOSPITAL AND LONG-TERM ISCHEMIC AND BLEEDING EVENTS IN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FINAL RESULTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
23. Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective
24. MYOCARDIAL INFARCTION WITH LEFT BUNDLE BRANCH BLOCK: A DEADLY DISEASE WITH A LOW RATE OF REPERFUSION TREATMENT
25. KNOWLEDGE TRANSLATION TO REDUCE DELAYS OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS IN QUÉBEC - INSIGHTS FROM THE AMI ON TIME STUDY
26. RISK OF BLEEDING COMPLICATIONS IN PATIENTS TREATED WITH TICAGRELOR UNDERGOING URGENT CORONARY ARTERY BYPASS GRAFTING SURGERY: A SINGLE CENTER EXPERIENCE
27. NUMBER OF TRADITIONAL CARDIOVASCULAR RISK FACTORS AND MANAGEMENT AND OUTCOME IN ACUTE CORONARY SYNDROME
28. BLEEDING AND ISCHEMIC EVENTS IN CANADIAN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT) AT 1 YEAR
29. PATTERNS OF ADP RECEPTOR INHIBITOR USE DURING THE INDEX HOSPITALIZATION IN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)
30. A COMPARISON OF QUALITY OF CARE OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION BY CHOICE OF REPERFUSION STRATEGY: RESULTS OF A QUÉBEC-WIDE, SYSTEMATIC FIELD EVALUATION (2013-14)
31. PRE NATAL MANIFESTATIONS OF HYPERTHYROIDISM
32. Balloon Angioplasty of Native Aortic Coarctation Vs. Post Surgical Correction in Infants Under 12-Month-Old at Chu Sainte Justine: Short and Mid-Term Results
33. Dual Antiplatelet Patterns in Patients With Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Prospective Canadian Observational Antiplatelet Study (COAPT)
34. Underutilization of Newer Guideline-Recommended Oral Antiplatelet Therapy: Insights From the Canadian Acute Coronary Syndrome (ACS) Reflective
35. 790 Impact of Beta-Blockers on Long-Term Survival in the Reperfusion Era
36. 232 Type of reperfusion therapy and impact on long-term survival in patients with St-elevation myocardial infarction: Insight from the AMI-Québec Study
37. 902 The evaluation of the influence of statins and proton pump inhibitors on clopidogrel antiplatelet effects (SPICE) trial
38. USEFULNESS OF PRE-HOSPITAL ECG IN STEMI PATIENTS PRESENTING DIRECTLY TO A PRIMARY PCI CENTER
39. PERCUTANEOUS CORONARY INTERVENTION IS ASSOCIATED WITH UNNECESSARY DELAYS IN INITIATION OF MILD THERAPEUTIC HYPOTHERMIA IN PATIENTS WITH CARDIAC ARREST
40. 438 Use of pre-hospital ECG improves time to reperfusion in STEMI patients
41. 436 Prevalence, characterization and clinical impact of chronic total occlusion in patients with acute ST-elevation myocardial infarction
42. 335 Cytochrome P450 2C19*17 polymorphism offsets the negative effect of 2C19*2 polymorphism on platelet reactivity in patients treated with clopidogrel
43. 336 PON1-Q192R polymorphism has no effect on platelet reactivity in patients treated with clopidogrel
44. 239 Predicting high on-treatment platelet reactivity in patients with acute coronary syndromes: Role of body mass index and waist circumference
45. 219 Reaching target lipid levels after stemi in canada: Reasons for failure
46. Left main mycotic aneurysm causing myocardial infarction
47. Splenic infarction associated with a mobile aortic valve lesion: A case report and review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.